Physician profile
Eli Reshef
NPI 1982655577
$3,737.49
in general payments reported to CMS, 2019-2025
24 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $216 · 2021: $781 · 2022: $585 · 2023: $276 · 2024: $278 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688 · Education: $19.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.19 |
| Education | $19.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,401.43 | 2019-2025 | Menopur, Endometrin |
| Abbvie INC. | $572.88 | 2019-2022 | |
| Organon LLC | $312.14 | 2021-2024 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Merck Sharp & Dohme LLC | $269.35 | 2019-2021 | |
| Coopersurgical, INC. | $194.90 | 2020-2023 | Stripper |
| Emd Serono, INC. | $166.85 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $129.63 | 2021-2023 | |
| Therapeuticsmd, INC. | $94.77 | 2019-2021 | |
| Myovant Sciences INC. | $90.04 | 2021-2022 | |
| Sage Therapeutics, LLC | $77.85 | 2021-2022 | |
| Myriad Women'S Health, INC. | $67.56 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.75 | 2019-2022 | |
| Hamilton Thorne, INC. | $53.39 | 2025 | Lykos, Guardia, Cook |
| Hologic Sales and Service, LLC | $49.81 | 2024-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Fluent Fluid Management System |
| Baxter Healthcare | $35.78 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $26.93 | 2023 | Myfembree |
| Ultragenyx Pharmaceutical INC. | $23.44 | 2021 | |
| Avanos Medical | $19.32 | 2020 | |
| Galen US INC | $18.06 | 2019 | |
| Roche Diagnostics Corporation | $15.94 | 2021 | |
| Vertical Pharmaceuticals, LLC | $15.31 | 2019 | |
| Medtronic, INC. | $13.83 | 2022 | |
| Avion Pharmaceuticals | $12.80 | 2022 | |
| Acessa Health INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Reshef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.